JPMorgan Chase & Co’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.3M | Sell |
|
|||||
|
2025
Q1 | $45.5M | Buy |
|
|||||
|
2024
Q4 | $53.2M | Buy |
|
|||||
|
2024
Q3 | $38.5M | Buy |
|
|||||
|
2024
Q2 | $2.79M | Buy |
|
|||||
|
2024
Q1 | $1.58M | Sell |
|
|||||
|
2023
Q4 | $2.43M | Buy |
|
|||||
|
2023
Q3 | $1.72M | Sell |
|
|||||
|
2023
Q2 | $3.05M | Buy |
|
|||||
|
2023
Q1 | $1.17M | Buy |
|
|||||
|
2022
Q4 | $82K | Sell |
|
|||||
|
2022
Q3 | $155K | Buy |
|
|||||
|
2022
Q2 | $74K | Sell |
|
|||||
|
2022
Q1 | $194K | Buy |
|
|||||
|
2021
Q4 | $149K | Buy |
|
|||||
|
2021
Q3 | $46K | Buy |
|
|||||
|
2021
Q2 | $38K | Sell |
|
|||||
|
2021
Q1 | $116K | Buy |
|
|||||
|
2020
Q4 | $1K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.21M | Buy |
|
|||||
|
2020
Q1 | $568K | Sell |
|
|||||
|
2019
Q4 | $768K | Buy |
|
|||||
|
2019
Q3 | $190K | Sell |
|
|||||
|
2019
Q2 | $332K | Sell |
|
|||||
|
2019
Q1 | $979K | Sell |
|
|||||
|
2018
Q4 | $1.2M | Buy |
|
|||||
|
2018
Q3 | $111K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $27K | Sell |
|
|||||
|
2017
Q2 | $34K | Buy |
|
|||||
|
2017
Q1 | $14K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $14K | Buy |
|
|||||
|
2016
Q2 | $1K | Buy |
|